June 21, 2010

ABBOTT LABS: Bid to Revoke Bayer’s Humera Patent Still Pending

COMPANIES: Abbott Laboratories Inc

Subscribe

Abbott Laboratories’ application to revoke Bayer HealthCare LLC’s Humira(R) patent remains pending.

In its 2009 annual report on Form 10-K, Abbott reported that litigation is pending in the Regional Court in…

TO CONTINUE READING,LOGIN or

TOPICS: Drugs/Pharmaceuticals | Health Care | Legal Issues, Litigation | Patents, Intellectual Prop. | SEC-Qtrly, Annual Reports | Securities & Exch Comm, US

LOCATIONS: